RECOVERY Trial (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "RECOVERY Trial" in English language version.

refsWebsite

Global rank English rank

19nih.gov

4^th place

10doi.org

2^nd place

9recoverytrial.net

low place

4bbc.co.uk

8^th place

10^th place

3medrxiv.org

low place

2theguardian.com

12^th place

11^th place

2handle.net

102^nd place

76^th place

1isrctn.com

low place

1semanticscholar.org

11^th place

8^th place

1clinicaltrials.gov

5,225^th place

4,062^nd place

1web.archive.org

1^st place

1ukri.org

low place

1science.org

1,160^th place

737^th place

1ox.ac.uk

613^th place

456^th place

1gpni.co.uk

low place

1straitstimes.com

543^rd place

346^th place

1reuters.com

49^th place

47^th place

1aa.com.tr

754^th place

1,313^th place

1hdruk.ac.uk

low place

1nytimes.com

7^th place

1who.int

195^th place

302^nd place

1worldcat.org

5^th place

aa.com.tr

"South Africa approves dexamethasone to treat COVID-19". www.aa.com.tr.

bbc.co.uk

"Coronavirus: Dexamethasone being used to treat NHS patients today". BBC News. 17 June 2020. Retrieved 17 June 2020.
Gallagher J (25 March 2021). "Covid: The London bus trip that saved maybe a million lives". BBC News.
Fergus Walsh (20 June 2020). "At last some good news about coronavirus". BBC News. Retrieved 20 June 2020.
Michelle Roberts (11 February 2021). "Arthritis drug tocilizumab cuts deaths from Covid". BBC News Online. BBC. Retrieved 11 February 2021.

clinicaltrials.gov

Clinical trial number NCT04381936 for "Randomised Evaluation of COVID-19 Therapy (RECOVERY)" at ClinicalTrials.gov. 2 March 2021; page is updated from time to time.

doi.org

"Biggest COVID-19 trial tests repurposed drugs first". Nature Biotechnology. 38 (5): 510. 11 May 2020. doi:10.1038/s41587-020-0528-x. PMID 32393915. S2CID 218593584.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. (July 2020). "Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report". New England Journal of Medicine. 384 (8): 693–704. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530.
Mahase E (June 2020). "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. doi:10.1136/bmj.m2512. PMID 32576548.
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. (2 September 2020). "Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330–1341. doi:10.1001/jama.2020.17023. PMC 7489434. PMID 32876694.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, et al. (5 October 2020). "Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". The Lancet. 396 (10259): 1345–1352. doi:10.1016/S0140-6736(20)32013-4. PMC 7535623. PMID 33031764.
RECOVERY Collaborative Group (13 February 2021). "Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Lancet. 397 (10274): 605–612. doi:10.1016/S0140-6736(21)00149-5. hdl:10044/1/86993. PMC 7884931. PMID 33545096.
RECOVERY Collaborative Group (14 May 2021). "Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial". The Lancet. 397 (10289): 2049–2059. doi:10.1016/S0140-6736(21)00897-7. ISSN 0140-6736. PMC 8121538. PMID 34000257.
Gupta S, Leaf DE (May 2021). "Tocilizumab in COVID-19: some clarity amid controversy". Lancet. 397 (10285): 1599–1601. doi:10.1016/S0140-6736(21)00712-1. PMC 8084409. PMID 33933194.
RECOVERY Collaborative Group (1 May 2021). "Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Lancet. 397 (10285): 1637–1645. doi:10.1016/S0140-6736(21)00676-0. hdl:2164/16630. PMC 8084355. PMID 33933206.
Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, et al. (January 2024). "Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Nature Communications. 15 (1): 924. doi:10.1038/s41467-023-43644-x. PMC 10831058. PMID 38296965.

gpni.co.uk

"Dexamethasone in COVID-19" (PDF). 16 June 2020. Retrieved 23 June 2020.

handle.net

hdl.handle.net

RECOVERY Collaborative Group (13 February 2021). "Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Lancet. 397 (10274): 605–612. doi:10.1016/S0140-6736(21)00149-5. hdl:10044/1/86993. PMC 7884931. PMID 33545096.
RECOVERY Collaborative Group (1 May 2021). "Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Lancet. 397 (10285): 1637–1645. doi:10.1016/S0140-6736(21)00676-0. hdl:2164/16630. PMC 8084355. PMID 33933206.

hdruk.ac.uk

"The potential health and economic impact of dexamethasone treatment for patients with COVID-19". HDR UK. Retrieved 6 September 2020.

isrctn.com

"ISRCTN - ISRCTN50189673: A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus)". www.isrctn.com.

medrxiv.org

RECOVERY Collaborative Group (2020). "Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report". medRxiv 10.1101/2020.06.22.20137273v1.
Aguas R, Mahdi A, Shretta R, Horby P, Landray M, White LJ (30 July 2020). "The potential health and economic impact of dexamethasone treatment for patients with COVID-19". medRxiv 10.1101/2020.07.29.20164269v1.
Horby PW, Roddick A, Spata E, Staplin N, Emberson JR, Pessoa-Amorim G, et al. (14 December 2020). "Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". medRxiv 10.1101/2020.12.10.20245944v1.

nih.gov

nytimes.com

Roni Caryn Rabin (24 June 2020). "Breakthrough Drug for Covid-19 May Be Risky for Mild Cases". New York Times. Retrieved 25 June 2020.

ox.ac.uk

"Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19". University of Oxford. 16 June 2020. Retrieved 16 June 2020.

recoverytrial.net

"RECOVERY Trial". Retrieved 17 June 2020.
"International sites — RECOVERY Trial". www.recoverytrial.net. Retrieved 17 May 2021.
"Randomised evaluation of COVID-19 therapy (RECOVERY) – Trial protocol v11" (PDF). RECOVERY Trial. 21 November 2020. Retrieved 14 December 2020.
"Recovery Trial Protocol v15" (PDF). Recovery Trial. Retrieved 4 February 2021.
"No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY" (PDF). RECOVERY Trial: Statement from the Chief Investigators. 29 June 2020. Retrieved 30 June 2020.
"No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19". Recovery Trial, Nuffield Department of Population Health, University of Oxford, UK. 5 June 2020. Retrieved 7 June 2020.
Peter Horby, Martin Landray (14 December 2020). "RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19". RECOVERY Trial.
RECOVERY trial chief investigators (15 January 2021). "Recovery trial closes recruitment for convalescent plasma treatment for patients hospitalised with COVID-19". Retrieved 15 January 2021.
"Tocilizumab reduces deaths in patients hospitalised with COVID-19". Recovery Trial. 11 February 2021. Retrieved 11 February 2021.

reuters.com

"Taiwan provisionally approves dexamethasone as coronavirus treatment". Reuters. 4 August 2020. Retrieved 6 September 2020.

science.org

Kupferschmidt K (2 July 2020). "One U.K. trial is transforming COVID-19 treatment. Why haven't others delivered more results?". Science. Retrieved 19 October 2020.

semanticscholar.org

api.semanticscholar.org

"Biggest COVID-19 trial tests repurposed drugs first". Nature Biotechnology. 38 (5): 510. 11 May 2020. doi:10.1038/s41587-020-0528-x. PMID 32393915. S2CID 218593584.

straitstimes.com

hermesauto (22 July 2020). "Japan approves dexamethasone as coronavirus treatment". The Straits Times. Retrieved 6 September 2020.

theguardian.com

Boseley S (17 June 2020). "Dexamethasone: low-cost drug helps prevent deaths of sickest coronavirus patients". The Guardian.
Nicola Davis (11 February 2021). "Arthritis drug that helps Covid ICU patients has wider benefits, trial finds". The Guardian. Retrieved 11 February 2021.

ukri.org

"Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 - UK Research and Innovation". www.ukri.org. UK Research and Innovation. Archived from the original on 24 October 2020. Retrieved 19 October 2020.

web.archive.org

"Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 - UK Research and Innovation". www.ukri.org. UK Research and Innovation. Archived from the original on 24 October 2020. Retrieved 19 October 2020.

who.int

"WHO Director-General's opening remarks at the media briefing on COVID-19 - 22 June 2020". World Health Organization. Retrieved 25 June 2020.

worldcat.org

search.worldcat.org

RECOVERY Collaborative Group (14 May 2021). "Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial". The Lancet. 397 (10289): 2049–2059. doi:10.1016/S0140-6736(21)00897-7. ISSN 0140-6736. PMC 8121538. PMID 34000257.

RECOVERY Trial (English Wikipedia)

aa.com.tr

bbc.co.uk

clinicaltrials.gov

doi.org

gpni.co.uk

handle.net

hdl.handle.net

hdruk.ac.uk

isrctn.com

medrxiv.org

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

covid19treatmentguidelines.nih.gov

nytimes.com

ox.ac.uk

recoverytrial.net

reuters.com

science.org

semanticscholar.org

api.semanticscholar.org

straitstimes.com

theguardian.com

ukri.org

web.archive.org

who.int

worldcat.org

search.worldcat.org